Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fore Kopi Indonesia Tbk. (FORE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Fore Kopi Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Fore Kopi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp775 (market cap 7.09T, 4.99M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 42.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (4.99M versus 324K). Which is the better fit depends on your goals.

FOREOBAT
Market Cap
7.09T166.01B
Volume
4.99M324K
Lot
49.86K3.24K
Turnover
3.88B77.68M
Average Price
777.82239.75
Value
3.88B77.68M
Indicative Equilibrium Price
775240
Indicative Equilibrium Volume
1.54K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FORE
View details
OBAT
View details

About Fore Kopi Indonesia Tbk.

PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.

Read more on FORE

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT